Created at Source Raw Value Validated value
June 25, 2024, noon usa

* clinical status according to the who scale - 1, 2, 3, 4 and 5 points. * increased risk of bleeding: * extensive bleeding at the present time; * intracranial (including subarachnoid) hemorrhage at the present time. * lactation, pregnancy * known hypersensitivity to fortelyzin®.

* clinical status according to the who scale - 1, 2, 3, 4 and 5 points. * increased risk of bleeding: * extensive bleeding at the present time; * intracranial (including subarachnoid) hemorrhage at the present time. * lactation, pregnancy * known hypersensitivity to fortelyzin®.

Nov. 29, 2021, 10:30 p.m. usa

clinical status according to the who scale - 1, 2, 3, 4 and 5 points. increased risk of bleeding: extensive bleeding at the present time; intracranial (including subarachnoid) hemorrhage at the present time. lactation, pregnancy known hypersensitivity to fortelyzin®.

clinical status according to the who scale - 1, 2, 3, 4 and 5 points. increased risk of bleeding: extensive bleeding at the present time; intracranial (including subarachnoid) hemorrhage at the present time. lactation, pregnancy known hypersensitivity to fortelyzin®.